In Cell Western Blotting for Quantifying Protein Expression in 3D Tumor-Stroma Microfluidic Device

After more than 40 years since the signing of the National Cancer Act in 1970, cancer remains a formidable challenge. Cancer is currently the second most common cause of death in the United States, and worldwide cancer cases are projected to rise 50% between 2012 and 2030 [1-2].